Summary
The White House dropped Dr. Heidi Overton’s nomination to lead the Food and Drug Administration on Tuesday. Republican senators had raised concerns about her positions on abortion, vaccines and vaping.Key Facts
- President Donald Trump nominated Heidi Overton to lead the FDA.
- The White House dropped Overton’s nomination on Tuesday, November 17, 2026.
- Some Republican senators had concerns about Overton’s positions on abortion, vaccines and vaping.
- Overton’s nomination faced difficulty among Republican members of the Senate committee considering it.
- Overton testified before the Senate Health, Education, Labor, and Pensions Committee on September 24, 2026.